Posted on January 4th, 2013 by Logan Lafferty
NeoChord Inc., a Mayo Clinic spin-off that makes technology for repairing heart valves, has received regulatory approval to sell its device in Europe. The Eden Prairie-based company will begin selling the device in Europe this month, NeoChord CEO John Seaberg said in an interview. The company makes artificial heart "strings" and an accompanying device that treat mitral valve regurgitation, a condition that causes heart valves to not close tightly enough.
Mpls St. Paul Business Journal by Katharine Grayson
You must be logged-in to the site to post a comment.